NEW YORK: Vaccine creator Novavax Inc said on Monday it has pushed back the beginning of a U.S.- based, late-stage preliminary for its test COVID-19 immunization and now anticipates that it should start in the coming a long time rather than November.

It is the second time that Novavax, which as of now has a late-stage UK preliminary in progress, has rescheduled the Phase 3 preliminary after first hailing an October start, hampered by issues in scaling up its assembling.
Portions of the U.S.- based organization, which lingers behind bigger adversaries Pfizer Inc and Moderna Inc in their COVID-19 antibody improvement timetables, fell 6% on the most recent deferral.
Get Latest News
Website -
News Source -
Bollywood News -
Tech News -
Business News -

More Details

Total Views:19
Reference Id:#1590918
Phone Number:8377910219
Website URL:Click To Visit
Current Rating: /5 0 Vote


Copyright © 2021 |   All Rights Reserved | |   24x7 support |   Email us : info[at]